sulfacetamide sodium 100 MG/ML Ophthalmic Solution [Bleph-10]

RxCUI: 1006122
RxNorm name: sulfacetamide sodium 100 MG/ML Ophthalmic Solution [Bleph-10]
Display name: BLEPH-10 (Ophthalmic)
Full name: sulfacetamide sodium 100 MG/ML Ophthalmic Solution [Bleph-10]
Term type: SBD
Status: Active
Strength: 10%
Dose form: Sol
Route: Ophthalmic
Updated: 2026-06-13 07:05:00

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 092010
Active start: 092010
Multiple ingredient: NO
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
sulfacetamide sodium	100 MG / 1 ML	sulfacetamide	sulfacetamide sodium

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Ophthalmic Solution	7670

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
sulfacetamide	10169

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Bleph-10 10 % Ophthalmic Solution	1	NAMES
RxNorm Name	sulfacetamide sodium 100 MG/ML Ophthalmic Solution [Bleph-10]	1	NAMES
RxNorm Synonym	2 linked values Bleph-10 10 % Ophthalmic Solution Bleph-10 100 MG/ML Ophthalmic Solution	2	NAMES
TTY	SBD	1	ATTRIBUTES
RxCUI	1006122	1	CODES
MMSL_CODE	BD3170	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 11 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
52959027200	rxnav_ndcs	yes
52959027201	rxnav_ndcs	yes
00247052415	rxnav_historical
00247091005	rxnav_historical
11980001103	rxnav_historical
11980001105	rxnav_historical
11980001115	rxnav_historical
53002082571	rxnav_historical
53002082573	rxnav_historical
54569120800	rxnav_historical
55045195505	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
27c8bd30-89ec-464c-b7ac-ca2dbe27e861	BLEPH ® -10 (sulfacetamide sodium ophthalmic solution, USP) 10%	Allergan, Inc.	20140716
c9c19a24-9781-4b7e-83bb-0f7ea89fbf48		National Council for Prescription Drug Programs	20120724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	D10AF	Antiinfectives for treatment of acne	ATC1-4		sulfacetamide
ATC	S01AB	Sulfonamides	ATC1-4		sulfacetamide
FDASPL	D013449	Sulfonamides	CHEM	has_chemical_structure	sulfacetamide
FDASPL	N0000175503	Sulfonamide Antibacterial	EPC	has_epc	sulfacetamide
MEDRT	D013409	Sulfacetamide	CHEM	has_ingredient	sulfacetamide sodium
MEDRT	D013409	Sulfacetamide	CHEM	has_ingredient	sulfacetamide
MEDRT	D003320	Corneal Ulcer	DISEASE	may_treat	sulfacetamide
MEDRT	D003320	Corneal Ulcer	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D012628	Dermatitis, Seborrheic	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D012628	Dermatitis, Seborrheic	DISEASE	may_treat	sulfacetamide
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	sulfacetamide
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	sulfacetamide sodium
MEDRT	D004427	Ear Diseases	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D004427	Ear Diseases	DISEASE	may_treat	sulfacetamide
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	sulfacetamide sodium
MEDRT	D007231	Infant, Newborn	DISEASE	ci_with	sulfacetamide
MEDRT	D017192	Skin Diseases, Bacterial	DISEASE	may_treat	sulfacetamide
MEDRT	D017192	Skin Diseases, Bacterial	DISEASE	may_treat	sulfacetamide sodium
MEDRT	D014141	Trachoma	DISEASE	may_treat	sulfacetamide
MEDRT	D014141	Trachoma	DISEASE	may_treat	sulfacetamide sodium
MEDRT	N0000009946	Para-Aminobenzoic Acid Inhibitors	MOA	has_moa	sulfacetamide
MEDRT	N0000009946	Para-Aminobenzoic Acid Inhibitors	MOA	has_moa	sulfacetamide sodium
MEDRT	N0000008344	Cellular Growth Phase Arrest	PE	has_pe	sulfacetamide
MEDRT	N0000008344	Cellular Growth Phase Arrest	PE	has_pe	sulfacetamide sodium
MEDRT	N0000008347	Cellular Synthetic Activity Alteration	PE	has_pe	sulfacetamide
MEDRT	N0000008347	Cellular Synthetic Activity Alteration	PE	has_pe	sulfacetamide sodium
MEDRT	N0000009935	Decreased Folic Acid Modification	PE	has_pe	sulfacetamide
MEDRT	N0000009935	Decreased Folic Acid Modification	PE	has_pe	sulfacetamide sodium

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Bleph-10	rxnav_allrelated
DF	DF	Ophthalmic Solution	rxnav_allrelated
DFG	DFG	Ophthalmic Product	rxnav_allrelated
IN	IN	sulfacetamide	rxnav_allrelated
PIN	PIN	sulfacetamide sodium	rxnav_allrelated
SBD	SBD	sulfacetamide sodium 100 MG/ML Ophthalmic Solution [Bleph-10]	rxnav_allrelated
SBDC	SBDC	sulfacetamide sodium 100 MG/ML [Bleph-10]	rxnav_allrelated
SBDF	SBDF	sulfacetamide Ophthalmic Solution [Bleph-10]	rxnav_allrelated
SBDFP	SBDFP	sulfacetamide sodium Ophthalmic Solution [Bleph-10]	rxnav_allrelated
SBDG	SBDG	Bleph-10 Ophthalmic Product	rxnav_allrelated
SCD	SCD	sulfacetamide sodium 100 MG/ML Ophthalmic Solution	rxnav_allrelated
SCDC	SCDC	sulfacetamide sodium 100 MG/ML	rxnav_allrelated
SCDF	SCDF	sulfacetamide Ophthalmic Solution	rxnav_allrelated
SCDFP	SCDFP	sulfacetamide sodium Ophthalmic Solution	rxnav_allrelated
SCDG	SCDG	sulfacetamide Ophthalmic Product	rxnav_allrelated
SCDGP	SCDGP	sulfacetamide sodium Ophthalmic Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	100 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
NAMES	Prescribable Synonym	BLEPH-10 10 % Ophthalmic Solution
SOURCES	Source	Micromedex RED BOOK